Les évolutions de l’IA en médecineOctober 28, 2026

AI in medicine: from imaging to assistants, what progress is being made?

Imaging devices, multimodal assistants and drug research: understanding practical advances in medical AI and the limits of each use.

Artificial intelligence in medicine does not describe a single tool. Software that helps analyse an image, an assistant that summarises a document and a method used in a clinical trial meet different needs. Understanding progress means looking at the task performed and the evidence behind it.

Imaging: established uses with defined scope

The FDA list identifies AI-enabled medical devices authorised for marketing in the United States. It includes tools in radiology, ultrasound and cardiology. Medical AI has therefore moved beyond laboratory demonstrations.

However, the list concerns specific products and uses. It is not exhaustive, does not validate AI tools in general and does not constitute European authorisation.

Multimodal assistants expand the possibilities

Models that can process text and images open another field. In its 2024 guidance, the WHO describes possible applications in documenting consultations, training healthcare workers and research.

This potential does not guarantee reliable answers. WHO highlights errors, bias and the risk of trusting a machine too readily. Summarising a medical report may help organise information; that alone does not establish that a tool can diagnose a condition. Its intended context and human verification remain essential.

Drug research is also reaching milestones

In March 2025, EMA qualified a methodology using AIM-NASH to help a pathologist assess liver biopsies in clinical trials. This recognition concerns a method for generating evidence, rather than authorisation of a treatment.

The same page presents joint EMA–FDA principles published in January 2026 for AI use in drug development. Progress therefore also concerns how these tools are assessed and monitored.

Distinguishing technical progress from demonstrated benefit

Three questions help assess an announcement: what task does the tool perform, in what setting was it evaluated, and who checks its output? An impressive answer or a well-analysed image does not, by itself, demonstrate improved care.

AI is changing the tools available. Understanding their precise role makes it easier to appreciate progress while distinguishing assistance, experimentation and medical decisions.

Sources

Share this article

Read also